These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1127 related items for PubMed ID: 19875971

  • 21. [Pleural and parenchymal lung diseases from asbestos exposure. CT diagnosis].
    Polverosi R, Vigo M, Citton O.
    Radiol Med; 2000 Nov; 100(5):326-31. PubMed ID: 11213409
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. The role of positron emission tomography/computed tomography in the diagnosis of pleural diseases.
    Orki A, Akin O, Tasci AE, Ciftci H, Urek S, Falay O, Kutlu CA.
    Thorac Cardiovasc Surg; 2009 Jun; 57(4):217-21. PubMed ID: 19670115
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Assessment of 18F-fluorodeoxyglucose dual-head gamma camera in asbestos lung diseases.
    Melloni B, Monteil J, Vincent F, Bertin F, Gaillard S, Ducloux T, Verbeke S, Maubon A, Vandroux JC, Bonnaud F.
    Eur Respir J; 2004 Nov; 24(5):814-21. PubMed ID: 15516678
    [Abstract] [Full Text] [Related]

  • 32. Evaluation of pleural disease with 18-fluorodeoxyglucose positron emission tomography imaging.
    Duysinx B, Nguyen D, Louis R, Cataldo D, Belhocine T, Bartsch P, Bury T.
    Chest; 2004 Feb; 125(2):489-93. PubMed ID: 14769729
    [Abstract] [Full Text] [Related]

  • 33. Whole-Body MRI: Comparison of Its Capability for TNM Staging of Malignant Pleural Mesothelioma With That of Coregistered PET/MRI, Integrated FDG PET/CT, and Conventional Imaging.
    Ohno Y, Yui M, Aoyagi K, Kishida Y, Seki S, Koyama H, Yoshikawa T.
    AJR Am J Roentgenol; 2019 Feb; 212(2):311-319. PubMed ID: 30512992
    [Abstract] [Full Text] [Related]

  • 34. Diagnostic accuracy of 18F-FDG-PET and PET/CT in the differential diagnosis between malignant and benign pleural lesions: a systematic review and meta-analysis.
    Treglia G, Sadeghi R, Annunziata S, Lococo F, Cafarotti S, Bertagna F, Prior JO, Ceriani L, Giovanella L.
    Acad Radiol; 2014 Jan; 21(1):11-20. PubMed ID: 24331260
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Prognostic value of 18F-FDG PET/CT in patients with malignant pleural mesothelioma.
    Lee ST, Ghanem M, Herbertson RA, Berlangieri SU, Byrne AJ, Tabone K, Mitchell P, Knight SR, Feigen M, Scott AM.
    Mol Imaging Biol; 2009 Jan; 11(6):473-9. PubMed ID: 19330385
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Predictive value of F-18 FDG PET/CT for malignant pleural effusion in non-small cell lung cancer patients.
    Kim BS, Kim IJ, Kim SJ, Pak K, Kim K.
    Onkologie; 2011 Jan; 34(6):298-303. PubMed ID: 21625182
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 57.